Aliases:This biomarker is also known as:
- lutropin subunit beta,
- luteinizing hormone beta subunit,
- Lutropin beta chain,
- interstitial cell stimulating hormone, beta chain,
- luteinizing hormone beta polypeptide,
- Luteinizing hormone subunit beta,
The pituitary glycoprotein hormone family includes follicle stimulating hormone (FSH), luteinizing hormone (LH), chorionic gonadotropin (CG), and thyroid-stimulating hormone (TSH). All of these glycoproteins consist of an identical alpha subunit and a hormone-specific beta subunit. LHB, the beta subunit of luteinizing hormone, confers biological specificity. LH is expressed in the pituitary gland and promotes spermatogenesis and ovulation by stimulating the testes and ovaries to synthesize steroids. The genes for the beta chains of chorionic gonadotropin and for luteinizing hormone are contiguous on chromosome 19q13.3. Mutations in this gene are associated with hypogonadism which is characterized by infertility and pseudohermaphroditism.
There are no datasets associated with this biomarker.
The following organs have data associated with this biomarker…
LHB alone was not shown to be a strong predictor of ovarian cancer.
Despite many promising new markers for ovarian cancer, CA125 remains the single best biomarker in the phase II and phase III specimens tested in this study.
No associated publications found.
|UniProt Accession #:||P01229|
|Mutated Sites Count:||29|
|Associated Pubmed ID Count||6|
|Affected Protein Function Sites Count:||4|